Dr. Concepcion Vicenta Llorente Cortes | Biomedical | Best Researcher Award
Doctorate at Consejo Superior de Investigaciones Científicas, Spain
Profiles
Early Academic Pursuits
Dr. Concepción Vicenta Llorente Cortés began her academic journey with a Bachelor’s degree in Biology from the Universitat Autònoma de Barcelona, Spain, in 1989. Her passion for understanding complex biological systems led her to pursue advanced studies in Biochemistry, Molecular Biology, and Biomedicine, culminating in a doctoral degree in 1995 from the same institution. Her academic foundation set the stage for an illustrious career in biomedical research.
Professional Endeavors
Since 2006, Dr. Llorente Cortés has served as a Scientific Researcher at the Spanish National Research Council (CSIC) within the Pathology Department at IIBB-CSIC, Spain. Her earlier roles include positions as Postdoctoral Research Fellow and Senior Investigator with CSIC and the Fundación Investigación Cardiovascular, reflecting her steady progression in the field. Across these roles, she has made significant contributions to advancing cardiovascular research.
Contributions and Research Focus
Dr. Llorente Cortés is renowned for her expertise in natural and health sciences, focusing on translational research in cardiovascular diseases. Her groundbreaking work has led to the development of innovative therapies, including peptides targeting Tau aggregation, which won her the prestigious InnoPau Innovation Program in 2023. She has spearheaded 36 competitive projects, 25 as Principal Investigator, showcasing her leadership in collaborative scientific endeavors.
Impact and Influence
With 120 international publications, 82 as the last or corresponding author, and an impressive h-index of 34, Dr. Llorente Cortés’s research has significantly shaped the global scientific community. Over half of her publications rank among the top 25% most-cited worldwide, emphasizing her work’s global impact. Additionally, she has actively collaborated with international networks like CardioRNA and Cardiolinc, extending her influence beyond Spain.
Academic Cites and Recognition
Dr. Llorente Cortés’s work has garnered 3,150 citations, with 2,195 excluding self-citations. She has also contributed as a reviewer for esteemed organizations such as the National Agency for the Evaluation of Research and multiple cardiovascular societies. Her editorial roles with journals like Scientific Reports and Frontiers highlight her expertise and commitment to scientific discourse.
Technical Skills
Adept in advanced biochemistry and molecular biology techniques, Dr. Llorente Cortés has also applied these skills to translational research, securing three patents, including one granted in the USA and Europe. Her innovative methodologies have been pivotal in developing therapies for heart failure and other cardiovascular conditions.
Teaching and Mentorship
Dr. Llorente Cortés has mentored the next generation of scientists by supervising 14 doctoral theses, 10 master’s theses, and six undergraduate theses. Her dedication to education extends to international research supervision, including ERASMUS and EFSD grant-supported projects.
Legacy and Future Contributions
Dr. Llorente Cortés’s legacy includes her contributions to cardiovascular research, translational therapies, and international scientific collaborations. Her ongoing work, such as the CIBERINNOVA program’s heart failure therapy validation, ensures her influence will continue shaping biomedical research and innovation.
Publications
PCSK9 Antibodies Treatment Specifically Enhances the Macrophage-specific Reverse Cholesterol Transport Pathway in Heterozygous Familial Hypercholesterolemia
- Authors: Borràs, C., Canyelles, M., Girona, J., Blanco-Vaca, F., Escolà-Gil, J.C.
- Journal: JACC: Basic to Translational Science
- Year: 2024
sICAM-1 concentrations are associated with inflammation in contralateral carotid plaque in patients with ischemic stroke
- Authors: Puig, N., Camps-Renom, P., Garcia, E., Llorente-Cortés, V., Benitez, S.
- Journal: Clinica e Investigacion en Arteriosclerosis
- Year: 2024
Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis
- Authors: La Chica Lhoëst, M.T., Martinez, A., Claudi, L., Escolà-Gil, J.C., Llorente-Cortés, V.
- Journal: Frontiers in Cardiovascular Medicine
- Year: 2024
Transcriptional analysis reveals that the intracellular lipid accumulation impairs gene expression profiles involved in insulin response-associated cardiac functionality
- Authors: Actis Dato, V., Paz, M.C., Rey, F.E., Chiabrando, G.A., Ceschin, D.G.
- Journal: Scientific Reports
- Year: 2023
Soluble low-density lipoprotein receptor-related protein 1 as a surrogate marker of carotid plaque inflammation assessed by 18F-FDG PET in patients with a recent ischemic stroke
- Authors: Garcia, E., Camps-Renom, P., Puig, N., Benitez, S., Llorente-Cortés, V.
- Journal: Journal of Translational Medicine
- Year: 2023